• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GAX胶原蛋白治疗老年女性尿失禁:两年随访

GAX collagen in the treatment of urinary incontinence in elderly women: a two year follow up.

作者信息

Khullar V, Cardozo L D, Abbott D, Anders K

机构信息

Department of Obstetrics and Gynaecology, King's College Hospital, London, UK.

出版信息

Br J Obstet Gynaecol. 1997 Jan;104(1):96-9. doi: 10.1111/j.1471-0528.1997.tb10657.x.

DOI:10.1111/j.1471-0528.1997.tb10657.x
PMID:8988705
Abstract

OBJECTIVE

To determine the efficacy of GAX collagen in the treatment of elderly women with genuine stress incontinence.

DESIGN

A single centre prospective study.

SETTING

A London teaching hospital.

PARTICIPANTS

Thirty-four women older than 60 years of age with genuine stress incontinence diagnosed on videocystourethrography.

INTERVENTIONS

Up to three paraurethral injections of GAX collagen.

MAIN OUTCOME MEASURES

Subjective and pad test assessments performed pre-operatively, after one month, one year and two years after the first injection of collagen. Videocystourethrography and urethral pressure profilometry were carried out pre-operatively, after three months and one year.

RESULTS

There was a reduction in urinary leakage as measured on pad testing. After two years 77% of the surviving 26 women were symptomatically cured. Objectively after two years 48% of the women were cured and 9% were improved over their initial pre-treatment level of incontinence. The cure rate was the same whether or not the women had undergone previous vaginal surgery. The maximum urethral closure pressure was not increased with treatment indicating that collagen injections do not act by producing obstruction, but this should be interpreted with caution due to the small sample size.

CONCLUSION

GAX collagen is an effective method of treating urinary incontinence in the elderly and especially women who have undergone previous continence procedures. The technique is easy to perform and particularly suitable in those who are frail, but if failure occurs after two years consideration needs to be given to its cost effectiveness.

摘要

目的

确定GAX胶原蛋白治疗老年女性真性压力性尿失禁的疗效。

设计

单中心前瞻性研究。

地点

伦敦一家教学医院。

参与者

34名年龄超过60岁、经膀胱尿道造影诊断为真性压力性尿失禁的女性。

干预措施

最多进行三次尿道旁注射GAX胶原蛋白。

主要观察指标

在首次注射胶原蛋白术前、术后1个月、1年和2年进行主观和尿垫试验评估。术前、术后3个月和1年进行膀胱尿道造影和尿道压力测定。

结果

尿垫试验测量的漏尿量减少。两年后,在存活的26名女性中,77%症状治愈。客观上,两年后48%的女性治愈,9%的女性失禁程度较初始治疗前有所改善。无论女性之前是否接受过阴道手术,治愈率相同。治疗后最大尿道闭合压未升高,表明胶原蛋白注射并非通过产生梗阻起作用,但由于样本量小,对此应谨慎解读。

结论

GAX胶原蛋白是治疗老年女性尤其是之前接受过控尿手术的女性尿失禁的有效方法。该技术操作简便,特别适合身体虚弱者,但如果两年后治疗失败,需要考虑其成本效益。

相似文献

1
GAX collagen in the treatment of urinary incontinence in elderly women: a two year follow up.GAX胶原蛋白治疗老年女性尿失禁:两年随访
Br J Obstet Gynaecol. 1997 Jan;104(1):96-9. doi: 10.1111/j.1471-0528.1997.tb10657.x.
2
Incontinence in elderly women: is periurethral collagen an advance?
Br J Obstet Gynaecol. 1997 Feb;104(2):154-7. doi: 10.1111/j.1471-0528.1997.tb11036.x.
3
Collagen for female genuine stress incontinence after a minimum 2-year follow-up.
Br J Urol. 1997 Nov;80(5):757-61. doi: 10.1046/j.1464-410x.1997.00465.x.
4
Periurethral collagen injections for genuine stress incontinence: a 2-year follow-up.经尿道周围注射胶原蛋白治疗真性压力性尿失禁:2年随访
Br J Urol. 1995 Aug;76(2):156-60. doi: 10.1111/j.1464-410x.1995.tb07664.x.
5
Urodynamics: prediction, outcome and analysis of mechanism for cure of stress incontinence by periurethral collagen.尿动力学:经尿道周围注射胶原蛋白治疗压力性尿失禁的预测、疗效及机制分析
Br J Obstet Gynaecol. 1997 Feb;104(2):158-62. doi: 10.1111/j.1471-0528.1997.tb11037.x.
6
Para-urethral collagen implantation for female stress incontinence.经尿道旁胶原植入治疗女性压力性尿失禁
Br J Urol. 1991 Dec;68(6):586-9. doi: 10.1111/j.1464-410x.1991.tb15420.x.
7
Periurethral implantation of glutaraldehyde cross-linked collagen (Contigen) in women with type I or III stress incontinence: quantitative outcome measures.I型或III型压力性尿失禁女性患者经尿道周围植入戊二醛交联胶原蛋白(Contigen):定量结果测量
Br J Urol. 1995 Mar;75(3):359-63. doi: 10.1111/j.1464-410x.1995.tb07349.x.
8
Injection of glutaraldehyde cross-linked collagen for urinary incontinence: two-year efficacy by self-assessment.注射戊二醛交联胶原蛋白治疗尿失禁:两年自我评估疗效
Int J Urol. 1996 Mar;3(2):124-7. doi: 10.1111/j.1442-2042.1996.tb00496.x.
9
Endoscopic implantation of collagen (GAX) for the treatment of urinary incontinence.
Br J Urol. 1992 Jan;69(1):22-5. doi: 10.1111/j.1464-410x.1992.tb15451.x.
10
Periurethral collagen injection: a long-term follow-up study.尿道周围胶原注射:一项长期随访研究。
BJU Int. 1999 Dec;84(9):966-71. doi: 10.1046/j.1464-410x.1999.00321.x.

引用本文的文献

1
Nonsurgical transurethral radiofrequency collagen denaturation: results at three years after treatment.非手术经尿道射频胶原变性:治疗三年后的结果
Adv Urol. 2011;2011:872057. doi: 10.1155/2011/872057. Epub 2011 Dec 5.
2
Laparoscopic Burch colposuspension after failed sub-urethral tape procedures: a retrospective audit.
Int Urogynecol J Pelvic Floor Dysfunct. 2008 May;19(5):681-5. doi: 10.1007/s00192-007-0506-6. Epub 2007 Dec 8.
3
Current use of injectable agents for female stress urinary incontinence.注射剂目前在女性压力性尿失禁治疗中的应用
Rev Urol. 2005;7 Suppl 1(Suppl 1):S12-21.
4
Treatment options for stress urinary incontinence.压力性尿失禁的治疗选择。
Rev Urol. 2004;6 Suppl 3(Suppl 3):S29-47.
5
Emerging periurethral bulking agents for female stress urinary incontinence: is new necessarily better?用于女性压力性尿失禁的新型尿道周围填充剂:新的就一定更好吗?
Curr Urol Rep. 2006 Sep;7(5):405-13. doi: 10.1007/s11934-006-0012-2.
6
Patient-perceived outcomes in the treatment of stress urinary incontinence: focus on urethral injection therapy.压力性尿失禁治疗中患者感知的结果:聚焦于尿道注射疗法。
Int Urogynecol J Pelvic Floor Dysfunct. 2007 Feb;18(2):199-205. doi: 10.1007/s00192-006-0148-0. Epub 2006 Jul 18.
7
Use of collagen for the treatment of stress urinary incontinence: an update.胶原蛋白用于治疗压力性尿失禁:最新进展
Curr Urol Rep. 2000 Oct;1(3):208-13. doi: 10.1007/s11934-000-0021-5.